Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
20.07.23
/
50%
€31.22
Target price
20.07.24
€49.32
Performance (%)
-26.14%
Price
21.05.24
€23.06
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.14%. This prediction currently runs until 20.07.24. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | 8.979% | 8.979% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat